Cowen analyst Boris Peaker lowered the price target on Heron Therapeutics (NASDAQ: HRTX) to $34.00 (from $39.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Pacira Pharma (PCRX): HRTX CRL a 'Clear Positive' - RBCJune 29, 2020 10:15 AM Heron Therapeutics (HRTX) said defended at Evercore ISIJune 29, 2020 10:14 AM Increasing unusual option volume: WKHS HRTXJune 29, 2020 9:40 AM Pre-Open Stock Movers 06/29: (KNSA) (WKHS) (COTY) Higher; (ICPT) (HRTX) (BYND) Lower (more...)June 29, 2020 9:31 AM Heron Therapeutics (HRTX) to Resume Trading at 9:10 a.m.June 29, 2020 8:48 AM Heron Therapeutics (HRTX) Receives CRL for HTX-011 for Management of Postoperative PainJune 29, 2020 8:45 AM Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative PainJune 29, 2020 8:45 AM